In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
- Author
- MERAVIGLIA, S1 ; EBERL, M4 ; SCARPA, F1 ; ROBERTS, A1 ; CACCAMO, N1 ; STASSI, G2 ; DIELI, F1 ; HAYDAY, A. C5 ; VERMIJLEN, D6 ; TODARO, M2 ; BUCCHERI, S3 ; CICERO, G2 ; LA MENDOLA, C1 ; GUGGINO, G1 ; D'ASARO, M1 ; ORLANDO, V1
[1] Dipartimento di Biopatologia e Metodologie Biomediche, Palermo, Italy
[2] Dipartimento di Discipline Chirurgiche ed Oncologiche, Università di Palermo, Palermo, Italy
[3] Fondazione Istituto Oncologico del Mediterraneo, Catania, Italy
[4] Department of Infection, Immunity and Biochemistry, School of Medicine, Cardiff University, Cardiff, United Kingdom
[5] Peter Gorer Department of Immunobiology, and the Biomedical Research Centre, King's College at Guy's and St Thomas' Hospitals London, and London Research Institute, Cancer Research UK, London, United Kingdom
[6] Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium - Source
Clinical and experimental immunology (Print). 2010, Vol 161, Num 2, pp 290-297, 8 p ; ref : 46 ref
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Vγ9Vδ2 T cells cytokines cytotoxicity immunotherapy metastatic breast cancer
- Keyword (fr)
- Acide zolédronique Antirésorptif Biochimie Cancer du sein Cytokine Cytotoxicité Dose faible Homme Immunothérapie In vivo Interleukine 2 Lymphocyte T Manipulation Métastase Récepteur cellule T γ/δ Stade avancé Traitement Bisphosphonates Cancer Dérivé de l'acide diphosphonique Pathologie de la glande mammaire Pathologie du sein Tumeur maligne
- Keyword (en)
- Zoledronic acid Antiresorptive agent Biochemistry Breast cancer Cytokine Cytotoxicity Low dose Human Immunotherapy In vivo Interleukin 2 T-Lymphocyte Manipulation Metastasis γ/δ T cell receptor Advanced stage Treatment Bisphosphonates Cancer Diphosphonic acid derivatives Mammary gland diseases Breast disease Malignant tumor
- Keyword (es)
- Acido zoledrónico Antirresortivo Bioquímica Cáncer del pecho Citoquina Citotoxicidad Dosis débil Hombre Inmunoterapia In vivo Interleuquina 2 Linfocito T Manipulación Metástasis Receptor célula T γ/δ Estadio avanzado Tratamiento Bisfosfonatos Cáncer Difosfonico ácido derivado Glándula mamaria patología Seno patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A02 Analytical, structural and metabolic biochemistry
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Analytical, structural and metabolic biochemistry Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23009437
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1365-2249.2010.04167.x 
https://dx.doi.org/10.1111/j.1365-2249.2010.04167.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2249.2010.04167.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:44:\"Clinical and experimental immunology (Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"Clin. exp. immunol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"290\";s:8:\"\u0000*\u0000epage\";s:3:\"297\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-9104\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MERAVIGLIA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:8:\"EBERL, M\";i:1;s:9:\"SCARPA, F\";i:2;s:10:\"ROBERTS, A\";i:3;s:10:\"CACCAMO, N\";i:4;s:9:\"STASSI, G\";i:5;s:8:\"DIELI, F\";i:6;s:12:\"HAYDAY, A. C\";i:7;s:12:\"VERMIJLEN, D\";i:8;s:9:\"TODARO, M\";i:9;s:11:\"BUCCHERI, S\";i:10;s:9:\"CICERO, G\";i:11;s:13:\"LA MENDOLA, C\";i:12;s:10:\"GUGGINO, G\";i:13;s:10:\"D'ASARO, M\";i:14;s:10:\"ORLANDO, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CEXIAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2249.2010.04167.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:44:\"Clinical and experimental immunology (Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"Clin. exp. immunol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"290\";s:8:\"\u0000*\u0000epage\";s:3:\"297\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-9104\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MERAVIGLIA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:8:\"EBERL, M\";i:1;s:9:\"SCARPA, F\";i:2;s:10:\"ROBERTS, A\";i:3;s:10:\"CACCAMO, N\";i:4;s:9:\"STASSI, G\";i:5;s:8:\"DIELI, F\";i:6;s:12:\"HAYDAY, A. C\";i:7;s:12:\"VERMIJLEN, D\";i:8;s:9:\"TODARO, M\";i:9;s:11:\"BUCCHERI, S\";i:10;s:9:\"CICERO, G\";i:11;s:13:\"LA MENDOLA, C\";i:12;s:10:\"GUGGINO, G\";i:13;s:10:\"D'ASARO, M\";i:14;s:10:\"ORLANDO, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CEXIAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2249.2010.04167.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2249.2010.04167.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:44:\"Clinical and experimental immunology (Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"Clin. exp. immunol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"290\";s:8:\"\u0000*\u0000epage\";s:3:\"297\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-9104\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MERAVIGLIA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:8:\"EBERL, M\";i:1;s:9:\"SCARPA, F\";i:2;s:10:\"ROBERTS, A\";i:3;s:10:\"CACCAMO, N\";i:4;s:9:\"STASSI, G\";i:5;s:8:\"DIELI, F\";i:6;s:12:\"HAYDAY, A. C\";i:7;s:12:\"VERMIJLEN, D\";i:8;s:9:\"TODARO, M\";i:9;s:11:\"BUCCHERI, S\";i:10;s:9:\"CICERO, G\";i:11;s:13:\"LA MENDOLA, C\";i:12;s:10:\"GUGGINO, G\";i:13;s:10:\"D'ASARO, M\";i:14;s:10:\"ORLANDO, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CEXIAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2249.2010.04167.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:44:\"Clinical and experimental immunology (Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"Clin. exp. immunol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"290\";s:8:\"\u0000*\u0000epage\";s:3:\"297\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-9104\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MERAVIGLIA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:8:\"EBERL, M\";i:1;s:9:\"SCARPA, F\";i:2;s:10:\"ROBERTS, A\";i:3;s:10:\"CACCAMO, N\";i:4;s:9:\"STASSI, G\";i:5;s:8:\"DIELI, F\";i:6;s:12:\"HAYDAY, A. C\";i:7;s:12:\"VERMIJLEN, D\";i:8;s:9:\"TODARO, M\";i:9;s:11:\"BUCCHERI, S\";i:10;s:9:\"CICERO, G\";i:11;s:13:\"LA MENDOLA, C\";i:12;s:10:\"GUGGINO, G\";i:13;s:10:\"D'ASARO, M\";i:14;s:10:\"ORLANDO, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CEXIAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"In vivo manipulation of V\u03b39V\u03b42 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
